Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in WomenJared M. Baeten, Zeda Rosenberg, Felix Mhlanga et al.|New England Journal of Medicine|2016Cited by 768
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender WomenLinda‐Gail Bekker, Flavia Matovu Kiweewa, Moupali Das et al.|New England Journal of Medicine|2024Cited by 471
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in WomenJared M. Baeten, Zeda Rosenberg, Thesla Palanee‐Phillips et al.|Obstetrical & Gynecological Survey|2016Cited by 373
HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trialKhatija Ahmed, Julia D Welch, Jared M. Baeten et al.|The Lancet|2019Cited by 306
An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African WomenJennifer E. Balkus, Jared M. Baeten, Elizabeth R. Brown et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2016Cited by 159